These data suggest that a premalignant condition such as PIN, which often precedes the onset of invasive adenocarcinoma in humans38, is required for HFD to exert its MYC-amplifying effects in the prostate. The gene discussed is MYC; the disease is prostate intraepithelial neoplasia.